Publisher of Iranian Journals and Conference Proceedings

Please waite ..
Publisher of Iranian Journals and Conference Proceedings
Login |Register |Help |عضویت کتابخانه ها
Paper
Title

Evaluation of the Effect of Oral Clofibrate Intake on Neonatal Total Serum Bilirubin: a Randomized Clinical Trial

مجله علمی ناباروری ایران، دوره: 7، شماره: 3
Year: 1395
COI: JR_IRJN-7-3_002
Language: EnglishView: 149
متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

Buy and Download

متن کامل (فول تکست) این مقاله منتشر نشده و یا در سایت موجود نیست و امکان خرید آن فراهم نمی باشد.

Authors

Mahmood NouriShadkam - Associate Professor, Mother and Newborn Health Research Center, School of Medicine, Shahid Sadoughi University of Medical Sciences , Yazd, Iran
Mohmmad Javad Mohammadi - Pediatrician, Ayatolla Khatam Hospital, Yazd, Iran
Khadijeh Nasiriani - PhD, Assistant Professor of Nursing, Mother and Newborn Health Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Abstract:

Background: Clofibrate is a pharmacological agent, which affects the lipid metabolism. This compound could be involved in bilirubin accumulation and excretion process. Therefore, this study aimed to evaluate the effect of oral clofibrate intake on total serum bilirubin (TSB) of neonates hospitalized at Khatam Hospital. Methods: This clinical trial was conducted on 73 neonates with hyperbilirubinemia. Samples were divided into clofibrate (n=41) and control (n=32) groups. In the Clofibrate group, samples were given a single oral dose of 100 mg/kg clofibrate, whereas the control group received distilled water in an equal amount and color as placebo. Birth weight, type of delivery, gender, age and primary TSB level were recorded prior to the intervention and TSB was measured 24, 48 and 72 hours after the intervention. Results: In this study,no significant difference was observed between the groups on the first and third day of intervention in terms of mean TSB in neonates. However, a significant reduction was found on the second day in mean TSB of neonates, who received clofibrate (P=0.04). Conclusion: According to the results of this study, application of clofibrate was associated with faster alleviation of mean TSB and shorter duration of hospital stay without major side effects. Therefore, it is recommended that clofibrate be only used for clinical management of neonatal hyperbilirubinemia.

Keywords:

Paper COI Code

This Paper COI Code is JR_IRJN-7-3_002. Also You can use the following address to link to this article. This link is permanent and is used as an article registration confirmation in the Civilica reference:

https://civilica.com/doc/935255/

How to Cite to This Paper:

If you want to refer to this Paper in your research work, you can simply use the following phrase in the resources section:
NouriShadkam, Mahmood and Mohammadi, Mohmmad Javad and Nasiriani, Khadijeh,1395,Evaluation of the Effect of Oral Clofibrate Intake on Neonatal Total Serum Bilirubin: a Randomized Clinical Trial,https://civilica.com/doc/935255

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :

  • Ahadi A, Mirzarahimi M, Ahmadabadi F, Tavasoli A, Parvaneh N. ...
  • Olusanya BO, Ogunlesi TA, Kumar P, Boo NY, Iskander IF, ...
  • Petrova A, Mehta R, Birchwood G, Ostfeld B, Hegyi T. ...
  • Stoddard JJ, Cull WL, Jewett EA, Brotherton SE, Mulvey HJ, ...
  • Huang MJ, Kua KE, Teng HC, Tang KS, Weng HW, ...
  • Hamidi M, Mesripour A, Zamanzad B. Comparing the effect of ...
  • Bulbul A, Cayonu N, Sanli ME, Uslu S. Evaluation of ...
  • Lin KW, Humphrey ME. Putting prevention into practice. Screening of ...
  • Newman J. Re: Guidelines for detection, management and prevention of ...
  • Dennery PA. Pharmacological interventions for the treatment of neonatal jaundice. ...
  • Ah YM, Kim YM, Kim MJ, Choi YH, Park KH, ...
  • Litherland NB, Bionaz M, Wallace RL, Loor JJ, Drackley JK. ...
  • Lalloyer F, Staels B. Fibrates, glitazones, and peroxisome proliferator-activated receptors. ...
  • Eghbalian F, Monsef F, Alam Ghomi N, Monsef A. Effect ...
  • Kutz K, Kandler H, Gugler R, Fevery J. Effect of ...
  • Lindenbaum A, Hernandorena X, Vial M, Benattar C, Janaud JC, ...
  • Bucheli Jiménez ER, Quiróz Maldonado M, Flores Colín I. Chlorifibrate ...
  • Zahedpasha Y, Ahmadpour-Kacho M, Hajiahmadi M, Naderi S. Effect of ...
  • Mohammadzadeh A, Farhat AS, Iranpour R. Effect of clofibrate in ...
  • Bourget P, Broise I, Quinquis-Desmaris V, Gabilan JC. Pharmacokinetics of ...
  • Brun S, Carmona MC, Mampel T, Vinas O, Giralt M, ...
  • Steiner A, Weisser B, Vetter W. A comparative review of ...
  • Gabilan JC. Pharmacologic treatment of neonatal jaundice. A new approach. ...

Research Info Management

Certificate | Report | من نویسنده این مقاله هستم

اطلاعات استنادی این Paper را به نرم افزارهای مدیریت اطلاعات علمی و استنادی ارسال نمایید و در تحقیقات خود از آن استفاده نمایید.

Scientometrics

The specifications of the publisher center of this Paper are as follows:
Type of center: علوم پزشکی
Paper count: 3,391
In the scientometrics section of CIVILICA, you can see the scientific ranking of the Iranian academic and research centers based on the statistics of indexed articles.

Share this page

More information about COI

COI stands for "CIVILICA Object Identifier". COI is the unique code assigned to articles of Iranian conferences and journals when indexing on the CIVILICA citation database.

The COI is the national code of documents indexed in CIVILICA and is a unique and permanent code. it can always be cited and tracked and assumed as registration confirmation ID.

Support